Rezolute officer reports common stock purchases in Form 4

Rezolute, Inc. insider Sunil Patilal Karnawat, the company’s Chief Commercial Officer, reported open-market purchases of common stock.

Rhea-AI Filing Summary

Rezolute, Inc. insider Sunil Patilal Karnawat, the company’s Chief Commercial Officer, reported open-market purchases of common stock. On 12/15/2025, he bought 12,000 common shares at $1.6199 per share and an additional 100 common shares at $1.6 per share. Following these transactions, he directly owns 71,542 Rezolute common shares, with another 8,000 shares held in an individual retirement account and 1,898 shares held in a health savings account.

Insider Trade Summary

Net Buyer: 12,100 shares

Net Buy 4 txns

Insider Karnawat Sunil Ratilal

Role Chief Commercial Officer

Bought 12,100 shs ($20K)

Type	Security	Shares	Price	Value
Purchase	Common Shares	12,000	$1.6199	$19K
Purchase	Common Shares	100	$1.60	$160.00
holding	Common Shares	--	--	--
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 71,542 shares (Direct); Common Shares — 8,000 shares (Indirect, Held in Individual Retirement Account); Common Shares — 1,898 shares (Indirect, Held in Health Savings Account)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Rezolute, Inc. (RZLT) report in this Form 4?

The filing shows that Sunil Patilal Karnawat, Chief Commercial Officer of Rezolute, Inc., purchased 12,000 common shares at $1.6199 and 100 common shares at $1.6 on 12/15/2025.

Who is the reporting person in the Rezolute (RZLT) Form 4 filing?

The reporting person is Sunil Patilal Karnawat, who serves as Chief Commercial Officer of Rezolute, Inc.. The document is filed by one reporting person.

How many Rezolute (RZLT) shares does Sunil Karnawat own after the reported trades?

After the reported transactions, Sunil Karnawat directly owns 71,542 Rezolute common shares. He also has 8,000 shares held in an individual retirement account and 1,898 shares held in a health savings account.

When did the Rezolute (RZLT) insider share purchases take place?

The reported open-market purchases of Rezolute common shares by Sunil Karnawat occurred on 12/15/2025, which is listed as the date of the earliest transaction.

Were any derivative securities reported for Rezolute (RZLT) in this Form 4?

The document includes a header for Table II - Derivative Securities, but in the provided excerpt there are no specific derivative security transactions listed.

What type of ownership does Sunil Karnawat report for his Rezolute (RZLT) shares?

The filing shows direct ownership of 71,542 common shares and indirect ownership through an individual retirement account holding 8,000 shares and a health savings account holding 1,898 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 07:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Karnawat Sunil Ratilal

(Last) (First) (Middle)

C/O REZOLUTE, INC.

275 SHORELINE DRIVE, SUITE 500

(Street)

REDWOOD CITY CA 94065

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rezolute, Inc. [ RZLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	12/15/2025		P		12,000	A	$1.6199	71,442	D
Common Shares	12/15/2025		P		100	A	$1.6	71,542	D
Common Shares								8,000	I	Held in Individual Retirement Account
Common Shares								1,898	I	Held in Health Savings Account

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Sunil Patilal Karnawat	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.